Cannara Biotech (TSXV:LOVE) Days Sales Outstanding : 49.48 (As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech Days Sales Outstanding?

Cannara Biotech's average Accounts Receivable for the three months ended in Feb. 2024 was C$10.67 Mil. Cannara Biotech's Revenue for the three months ended in Feb. 2024 was C$19.68 Mil. Hence, Cannara Biotech's Days Sales Outstanding for the three months ended in Feb. 2024 was 49.48.

The historical rank and industry rank for Cannara Biotech's Days Sales Outstanding or its related term are showing as below:

TSXV:LOVE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 12.3 Med: 44.89 Max: 185.45
Current: 49.94

During the past 6 years, Cannara Biotech's highest Days Sales Outstanding was 185.45. The lowest was 12.30. And the median was 44.89.

TSXV:LOVE's Days Sales Outstanding is ranked better than
71.54% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.84 vs TSXV:LOVE: 49.94

Cannara Biotech's Days Sales Outstanding increased from Feb. 2023 (48.66) to Feb. 2024 (49.48).

Cannara Biotech Days Sales Outstanding Historical Data

The historical data trend for Cannara Biotech's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech Days Sales Outstanding Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Days Sales Outstanding

Get a 7-Day Free Trial

31.85

12.30

30.82

57.92

60.94

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Days Sales Outstanding	Get a 7-Day Free Trial															48.66	52.51	51.31	47.95	49.48

Competitive Comparison of Cannara Biotech's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's Days Sales Outstanding falls into.

Cannara Biotech Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Cannara Biotech's Days Sales Outstanding for the fiscal year that ended in Aug. 2023 is calculated as

	Days Sales Outstanding (A: Aug. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Aug. 2022 )	+	Accounts Receivable (A: Aug. 2023 ))	/	count )	/	Revenue (A: Aug. 2023 )	*	Days in Period
=	( (8.527	+	10.593)	/	2 )	/	57.26	*	365
=	9.56					/	57.26	*	365
=	60.94

Cannara Biotech's Days Sales Outstanding for the quarter that ended in Feb. 2024 is calculated as:

	Days Sales Outstanding (Q: Feb. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Nov. 2023 )	+	Accounts Receivable (A: Feb. 2024 ))	/	count )	/	Revenue (A: Feb. 2024 )	*	Days in Period
=	( (9.881	+	11.466)	/	2 )	/	19.683	*	365 / 4
=	10.6735					/	19.683	*	365 / 4
=	49.48

Cannara Biotech (TSXV:LOVE) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Cannara Biotech Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives